about
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer.Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker.Targeting chemokine receptors in disease--a case study of CCR4Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse modelThe four types of Tregs in malignant lymphomas.Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death.Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.Antibody therapy for Adult T-cell leukemia-lymphoma.Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab.Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report.A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide.Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis.Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma.The role of G protein-coupled receptors in lymphoid malignancies.CD4⁺ CD25⁺ FOXP3⁺ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis.Therapeutic cancer vaccines.Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.Expression of multiple cytokines and chemokine receptor 4 in angioimmunoblastic T-cell lymphoma with abundant plasma cell infiltration involving the skin.The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.
P2860
Q33420837-A422A919-FC53-4619-BB19-F171FB3B8624Q33944201-E93A425C-0C11-4FFA-8824-6EC0FD37777AQ35196650-5EE4644F-1470-48BB-AF04-ECEDCF53C89CQ35713297-A2A20915-AC5C-47F2-A944-9D957EB29FCCQ36669046-907F003B-B902-4F5A-9D09-8D16C35C789EQ36821149-5578CFD1-FE3E-455C-9F92-C81CE8EAB82BQ37966000-210BAAA6-B2AF-4A12-AA8D-3A63C9D5CE70Q38286374-37D0CA01-9B97-4B98-B50F-44B63760155BQ38869610-F5D51AF0-A0F1-4678-B516-3FB8EB02D0A8Q38889427-4C5C24F2-9D07-4C1A-BBBF-AB4661B785CEQ39155541-09DE8CA5-CCB7-49E3-B3EE-E8CF58C366D1Q39611634-7BFD5424-DD60-464B-9D31-F7508A3132CDQ39698098-9B6CD066-8461-4B39-863B-8729E181CA70Q41442058-908802A7-EBD5-4D83-A4E6-0D82605F2D17Q41514638-383A11DF-A00D-471A-9EB0-E86094C6448CQ41527521-CE799568-FEDA-458D-B851-4C16812E3EADQ41816496-8C6CFA24-3918-407A-908B-83D83947E288Q42141309-C5148278-5210-4369-B625-7EEC138FE3F3Q43025486-477C6434-E992-4E5A-8840-7D19D7879DEAQ44612613-8D45A481-3C9B-4BAB-8B61-CEE9F453CE39Q45354913-812A5F3D-6DCE-4418-BFDE-BC6227AC8E16Q46774503-F200AF8D-719C-4692-B03E-9FEADFADCE58Q47960121-6D26959B-F799-4285-AA27-848EA7E84C35Q50908235-18C41570-0673-4F58-A61D-EF0F6866D68FQ50988785-A8BBEDA4-F9E0-424C-87BA-E52CADC4B448Q51048607-FB022FD8-030E-4A68-824F-59F09803852EQ52875383-A4687594-4F82-48D7-ACE4-8D76D28355FAQ54957634-D4230EFC-C4C0-43A9-B028-4036A203DD9F
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Immunopathogenesis of lymphoma: focus on CCR4.
@en
Immunopathogenesis of lymphoma: focus on CCR4.
@nl
type
label
Immunopathogenesis of lymphoma: focus on CCR4.
@en
Immunopathogenesis of lymphoma: focus on CCR4.
@nl
prefLabel
Immunopathogenesis of lymphoma: focus on CCR4.
@en
Immunopathogenesis of lymphoma: focus on CCR4.
@nl
P1433
P1476
Immunopathogenesis of lymphoma: focus on CCR4.
@en
P2093
Ryuzo Ueda
P2860
P356
10.1111/J.1349-7006.2010.01767.X
P577
2010-11-02T00:00:00Z